pharmaphorum6d
Lilly gets second approval, in Japan, for Alzheimer's drug
Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...
Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
pharmaphorum22d
Lilly moves Crohn's drug into phase 3, faces safety setback in Japan
Pharmacists will be able to substitute Eli Lilly’s insulin Lispro for Sanofi’s Humalog. Concerns over Verzenio in Japan However there were worries for Lilly in Japan, after it was reported ...
Independent Journal Review7d
Business Giants, Foreign Countries Have Already Committed To Pouring Over $1 Trillion Into US Since Trump’s Return
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
Devdiscourse4d
Eli Lilly's Global Expansion Plan for Blockbuster Drug Mounjaro
Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...
Eli Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...